Enanta outlines 2026 milestones for RSV and immunology programs

Go back to Enanta outlines 2026 milestones for RSV and immunology programs
ENANTA PHARM (NASDAQ: ENTA) Delayed: 13.13 -0.38 (2.81%)
Previous Close $13.51    52 Week High $34.49 
Open $13.42    52 Week Low $20.39 
Day High $13.50    P/E N/A 
Day Low $12.93    EPS $-3.18 
Volume 194,822